Rznomics Inc. continued South Korea’s year-end biotech rally with a ₩46.35 billion (US$31.35 million) IPO Dec. 18. Proceeds will fund Seongnam-si, South Korea-based Rznomic’s pipeline of gene ...

The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types of ...

Hansa Biopharma AB ( ($SE:HNSA) ) has issued an update. Hansa Biopharma AB announced that CEO Renée Aguiar-Lucander will present at J.P. Morgan’s ...

Researchers have captured real-time "molecular movies" showing how an enzyme changes shape during catalysis. The study was ...

An international research team has identified a human protein, ANKLE1, as the first DNA-cutting enzyme (nuclease) in mammals ...

The first partner company is on the path to market, but the implications are clear: eXoZymes has created a scalable production engine for molecules that were previously too rare or expensive to make.

Researchers have captured the first detailed molecular snapshots of human polynucleotide phosphorylase (hPNPase) in action, ...

That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...

Scientists at MD Anderson Cancer Center discovered that the mitochondrial enzyme GFER promotes an immunosuppressive tumor ...

Scott Nelson, left, and Nathaniel Kallmyer work in the laboratory of Zymosense, a startup company based in the Iowa State ...

A meta-analysis finds that mobile health tools, such as apps and text messages, support weight management and improve liver ...

In a groundbreaking study, researchers have captured real-time "molecular movies" showing how an enzyme changes shape during catalysis. Using an ...